Dejana Braithwaite,
Professor
Department:
MD-AGING/ GERIATRIC RES-OTHER
Business Phone:
(352) 273-5468
Business Email:
dbraithwaite@ufl.edu
Accomplishments
Inductee
2017
·
Royal Society of Medicine (UK)
Member, Expert Panel
2015
·
National Academy of Sciences, Institute of Medicine, National Cancer Policy Forum
Mentored Research Scholar Award
2012-2017
·
American Cancer Society
Career Catalyst Award
2011-2014
·
Susan Komen Foundation
Junior Investigator Award
2011
·
National Center of Excellence in Women’s Health, University of California, San Francisco
Junior Investigator Award
2010
·
Academic Senate, University of California, San Francisco
Developmental Award
2009
·
NIH Bay Area Breast Cancer Specialized Program of Research Excellence (SPORE)
Hellman Foundation Award for Early Career Faculty
2009
·
University of California, San Francisco
Cancer Prevention Research Fellowship (1 awarded nationally in the United States)
2007
·
Prevent Cancer Foundation/American Society for Preventive Oncology
Scholar-in-Training Award
2003
·
American Association for Cancer Research, Frontiers in Cancer Prevention
Pre-doctoral Fellowship (2 awarded nationally in the United Kingdom)
2000
·
Cancer Research U.K.
Publications
2021
Immunotherapy Utilization Among Patients With Metastatic NSCLC: Impact of Comorbidities.
Journal of immunotherapy (Hagerstown, Md. : 1997).
44(5):198-203
[DOI] 10.1097/CJI.0000000000000366.
[PMID] 33758148.
2021
Self-rated health in relation to fruit and vegetable consumption and physical activity among older cancer survivors.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
29(5):2713-2722
[DOI] 10.1007/s00520-020-05782-6.
[PMID] 32979089.
2021
Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019.
The Lancet. Public health.
[DOI] 10.1016/S2468-2667(21)00065-7.
[PMID] 34051920.
2021
Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019.
Lancet (London, England).
[DOI] 10.1016/S0140-6736(21)01169-7.
[PMID] 34051883.
2021
The association between cognitive impairment and breast and colorectal cancer screening utilization.
BMC cancer.
21(1)
[DOI] 10.1186/s12885-021-08321-6.
[PMID] 33975576.
2020
Author Correction: Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017.
Nature medicine.
26(8)
[DOI] 10.1038/s41591-020-0972-7.
[PMID] 32616917.
2020
Cervical neoplastic lesions in relation to CD4 T-lymphocyte counts and antiretroviral therapy among women with clinical stage 1 HIV in Yunnan, China.
The Kaohsiung journal of medical sciences.
36(6):450-459
[DOI] 10.1002/kjm2.12175.
[PMID] 31913555.
2020
Epidemiology and Molecular-Pathologic Characteristics of CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer.
Clinical colorectal cancer.
[DOI] 10.1016/j.clcc.2020.09.007.
[PMID] 33229221.
2020
Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study.
Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention.
26(Supp 1):i125-i153
[DOI] 10.1136/injuryprev-2019-043531.
[PMID] 32839249.
2020
Five insights from the Global Burden of Disease Study 2019.
Lancet (London, England).
396(10258):1135-1159
[DOI] 10.1016/S0140-6736(20)31404-5.
[PMID] 33069324.
2020
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019.
Lancet (London, England).
396(10258):1160-1203
[DOI] 10.1016/S0140-6736(20)30977-6.
[PMID] 33069325.
2020
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
Lancet (London, England).
396(10258):1223-1249
[DOI] 10.1016/S0140-6736(20)30752-2.
[PMID] 33069327.
2020
Impact of healthcare access and HIV testing on utilisation of cervical cancer screening among US women at high risk of HIV infection: cross-sectional analysis of 2016 BRFSS data.
BMJ open.
10(1)
[DOI] 10.1136/bmjopen-2019-031823.
[PMID] 31911515.
2020
Is education or income associated with insufficient fruit and vegetable intake among cancer survivors? A cross-sectional analysis of 2017 BRFSS data.
BMJ open.
10(12)
[DOI] 10.1136/bmjopen-2020-041285.
[PMID] 33262193.
2020
Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017.
Nature medicine.
26(5):750-759
[DOI] 10.1038/s41591-020-0807-6.
[PMID] 32313249.
2020
Mobile Technologies and Cervical Cancer Screening in Low- and Middle-Income Countries: A Systematic Review.
JCO global oncology.
6:617-627
[DOI] 10.1200/JGO.19.00201.
[PMID] 32302236.
2020
Screening Mammography Outcomes: Risk of Breast Cancer and Mortality by Comorbidity Score and Age.
Journal of the National Cancer Institute.
112(6):599-606
[DOI] 10.1093/jnci/djz172.
[PMID] 31593591.
2020
The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017.
The lancet. Gastroenterology & hepatology.
5(1):42-54
[DOI] 10.1016/S2468-1253(19)30328-0.
[PMID] 31648970.
2019
Chronic inflammation and risk of lung cancer in older adults in the health, aging and body composition cohort study.
Journal of geriatric oncology.
10(2):265-271
[DOI] 10.1016/j.jgo.2018.07.008.
[PMID] 30078713.
2019
Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer.
BMC cancer.
19(1)
[DOI] 10.1186/s12885-019-6144-9.
[PMID] 31623592.
2019
Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype.
Breast cancer research and treatment.
174(1):209-218
[DOI] 10.1007/s10549-018-5056-8.
[PMID] 30465158.
2019
Optimizing selection of candidates for lung cancer screening: role of comorbidity, frailty and life expectancy.
Translational lung cancer research.
8(Suppl 4):S454-S459
[DOI] 10.21037/tlcr.2019.10.03.
[PMID] 32038937.
2019
Smoking cessation interventions for potential use in the lung cancer screening setting: A systematic review and meta-analysis.
Lung cancer (Amsterdam, Netherlands).
135:205-216
[DOI] 10.1016/j.lungcan.2019.06.024.
[PMID] 31446996.
2019
Socioeconomic gradients in cancer incidence by race and ethnicity in California, 2008-2012: the influence of tobacco use or screening detectable cancers.
Cancer causes & control : CCC.
30(7):697-706
[DOI] 10.1007/s10552-019-01172-4.
[PMID] 31065915.
2018
Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort.
JAMA internal medicine.
178(4):494-501
[DOI] 10.1001/jamainternmed.2017.8642.
[PMID] 29435563.
2018
Metabolic Syndrome and the Risk of Breast Cancer and Subtypes by Race, Menopause and BMI.
Cancers.
10(9)
[DOI] 10.3390/cancers10090299.
[PMID] 30200454.
2018
Screening mammography use in older women according to health status: a systematic review and meta-analysis.
Clinical interventions in aging.
13:1987-1997
[DOI] 10.2147/CIA.S171739.
[PMID] 30349218.
2018
The association of early life socioeconomic position on breast cancer incidence and mortality: a systematic review.
International journal of public health.
63(7):787-797
[DOI] 10.1007/s00038-017-1060-8.
[PMID] 29197969.
2017
Childhood Socioeconomic Position and Pubertal Onset in a Cohort of Multiethnic Girls: Implications for Breast Cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
26(12):1714-1721
[DOI] 10.1158/1055-9965.EPI-17-0496.
[PMID] 28939588.
2017
Emerging Trends in Family History of Breast Cancer and Associated Risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
26(12):1753-1760
[DOI] 10.1158/1055-9965.EPI-17-0531.
[PMID] 28986348.
2017
Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening Population.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
26(6):938-944
[DOI] 10.1158/1055-9965.EPI-16-0801.
[PMID] 28096200.
2017
Lifecourse socioeconomic status and cancer-related risk factors: Analysis of the WHO study on global ageing and adult health (SAGE).
International journal of cancer.
140(4):777-787
[DOI] 10.1002/ijc.30499.
[PMID] 27813060.
2017
Socio-economic status over the life course and obesity: Systematic review and meta-analysis.
PloS one.
12(5)
[DOI] 10.1371/journal.pone.0177151.
[PMID] 28510579.
2016
Alcohol consumption and mortality after breast cancer diagnosis: The health and functioning in women study.
Breast disease.
36(2-3):77-89
[DOI] 10.3233/BD-150202.
[PMID] 27662274.
2016
Benefits and Harms of Screening Mammography by Comorbidity and Age: A Qualitative Synthesis of Observational Studies and Decision Analyses.
Journal of general internal medicine.
31(5):561-72
[DOI] 10.1007/s11606-015-3580-3.
[PMID] 26831305.
2016
Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study.
International journal of cancer.
138(5):1118-28
[DOI] 10.1002/ijc.29868.
[PMID] 26413860.
2016
Life-course socioeconomic status and breast and cervical cancer screening: analysis of the WHO’s Study on Global Ageing and Adult Health (SAGE).
BMJ open.
6(11)
[DOI] 10.1136/bmjopen-2016-012753.
[PMID] 27881528.
2016
Multilevel factors associated with long-term adherence to screening mammography in older women in the U.S.
Preventive medicine.
89:169-177
[DOI] 10.1016/j.ypmed.2016.05.034.
[PMID] 27261409.
2016
Optimal breast cancer screening strategies for older women: current perspectives.
Clinical interventions in aging.
11:111-25
[DOI] 10.2147/CIA.S65304.
[PMID] 26893548.
2016
Utilization of screening mammography in older women according to comorbidity and age: protocol for a systematic review.
Systematic reviews.
5(1)
[PMID] 27716433.
View on:
PubMed
2015
Performance of digital screening mammography among older women in the United States.
Cancer.
121(9):1379-86
[DOI] 10.1002/cncr.29214.
[PMID] 25537958.
2015
Smoking and mortality after breast cancer diagnosis: the health and functioning in women study.
Cancer medicine.
4(2):315-24
[DOI] 10.1002/cam4.359.
[PMID] 25511535.
2014
A multilevel model of postmenopausal breast cancer incidence.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
23(10):2078-92
[DOI] 10.1158/1055-9965.EPI-14-0403.
[PMID] 25017248.
2014
Challenges and opportunities in international molecular cancer prevention research: An ASPO Molecular Epidemiology and the Environment and International Cancer Prevention Interest Groups Report.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
23(11):2613-7
[DOI] 10.1158/1055-9965.EPI-14-0848.
[PMID] 25277796.
2014
Long-term outcomes among African-American and white women with breast cancer: what is the impact of comorbidity?
Journal of geriatric oncology.
5(3):266-75
[DOI] 10.1016/j.jgo.2014.02.003.
[PMID] 24613574.
2013
Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI.
Journal of general internal medicine.
28(11):1454-62
[DOI] 10.1007/s11606-013-2507-0.
[PMID] 23760741.
2013
Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age.
Cancer.
119(22):3959-67
[DOI] 10.1002/cncr.28310.
[PMID] 24037812.
2013
Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
JAMA internal medicine.
173(9):807-16
[DOI] 10.1001/jamainternmed.2013.307.
[PMID] 23552817.
2013
Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?
Journal of the National Cancer Institute.
105(5):334-41
[DOI] 10.1093/jnci/djs645.
[PMID] 23385442.
2013
The impact of functional limitations on long-term outcomes among African-American and white women with breast cancer: a cohort study.
BMJ open.
3(10)
[DOI] 10.1136/bmjopen-2013-003232.
[PMID] 24114369.
2013
To screen or not to screen older women for breast cancer: a conundrum.
Future oncology (London, England).
9(6):763-6
[DOI] 10.2217/fon.13.64.
[PMID] 23718292.
2013
Undertaking cancer research in international settings: report from the american society for preventive oncology special interest group on international issues in cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
22(9):1638-41
[DOI] 10.1158/1055-9965.EPI-13-0655.
[PMID] 23845714.
2012
Cancer prevention for global health: a report from the ASPO International Cancer Prevention Interest Group.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
21(9):1606-10
[DOI] 10.1158/1055-9965.EPI-12-0848.
[PMID] 22850804.
2012
Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
21(7):1115-25
[DOI] 10.1158/1055-9965.EPI-11-1228.
[PMID] 22573797.
2012
Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review.
Breast cancer research and treatment.
136(2):521-33
[DOI] 10.1007/s10549-012-2276-1.
[PMID] 23053660.
2011
The relative importance of predictors of body mass index change, overweight and obesity in adolescent girls.
International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity.
6(2-2):e233-42
[DOI] 10.3109/17477166.2010.545410.
[PMID] 21244233.
2010
Long-term prognostic role of functional limitations among women with breast cancer.
Journal of the National Cancer Institute.
102(19):1468-77
[DOI] 10.1093/jnci/djq344.
[PMID] 20861456.
2010
Opportunities for cancer epidemiology and control in low- and middle-income countries: a report from the american society for preventive oncology international cancer prevention interest group.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
19(7):1665-7
[DOI] 10.1158/1055-9965.EPI-10-0523.
[PMID] 20615883.
2010
Pre-counseling education for low literacy women at risk of Hereditary Breast and Ovarian Cancer (HBOC): patient experiences using the Cancer Risk Education Intervention Tool (CREdIT).
Journal of genetic counseling.
19(5):447-62
[DOI] 10.1007/s10897-010-9303-3.
[PMID] 20490636.
2009
Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients.
International journal of cancer.
124(5):1213-9
[DOI] 10.1002/ijc.24054.
[PMID] 19058216.
2009
Socioeconomic status in relation to early menarche among black and white girls.
Cancer causes & control : CCC.
20(5):713-20
[DOI] 10.1007/s10552-008-9284-9.
[PMID] 19107561.
2005
Development of a risk assessment tool for women with a family history of breast cancer.
Cancer detection and prevention.
29(5):433-9
[PMID] 16055276.
View on:
PubMed
Grants
Jan 2020
ACTIVE
The benefits and harms of lung cancer screening in Florida
Role: Co-Investigator
Funding: NATL INST OF HLTH NCI
Education
Fellow, Epidemiology and Public Health
2017-2021
·
Royal Society of Medicine
Cancer Prevention Fellow
2006-2008
·
American Society of Preventive Oncology/Prevent Cancer Foundation
Postdoctoral Fellow, Center for Health and Community
2006-2007
·
University of California, San Francisco
Postdoctoral Fellow in Cancer Epidemiology
2004-2007
·
Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco
Postdoctoral Fellow in Health Services Research, Institute for Health Policy Studies
2004-2006
·
University of California, San Francisco
Fellow in Health Outcomes Research
2000-2004
·
Institute of Public Health, University of Cambridge, England and Cancer Research
Ph.D., Epidemiology
2000-2004
·
University of Cambridge, Institute of Public Health, Faculty of Clinical Medicine, England
M.Sc. (high honors), Public Health/Health Psychology
1998-1999
·
University College London/Kings College, England
B.Sc. (high honors), Psychology and Psychobiology
1995-1998
·
London Guildhall University, England
Contact Details
Phones:
- Business:
- (352) 273-5468
Emails:
- Business:
- dbraithwaite@ufl.edu